LUNG Q3 2022 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+1.8% YoY

Gross Profit

$10M75.2% margin

Operating Income

-$14M-103.2% margin

Net Income

-$14M-105.0% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$202M

Total Liabilities

$39M

Stockholders' Equity

$163M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$13M	+1.8%
Gross Profit	$10M	$10M	+4.2%
Operating Income	-$14M	-$10M	-42.7%
Net Income	-$14M	-$10M	-39.2%

Geographic Segments

UNITED STATES

$8M62%

EMEA

$4M33%

Asia Pacific

$637,0005%

Other International Geographical Areas

$58,0000%